aTTP | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

384 results for “aTTP”

Trials

View all 249 →

Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP

350 participants · First posted Aug 2, 2021

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

21 participants · First posted Aug 29, 2019

Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP

58 participants · First posted Jan 22, 2021

Drugs

View all 52 →

Caplacizumab(Cablivi)

Conditions: Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

ATAP

AdTP

Organizations

ATP SCIENCE PTY LTD

Australia

News

View all 82 →

EU Approves Sanofi's Cablivi as First Targeted Therapy for Rare Blood Clotting Disorder aTTP

Sanofi Secures Chinese Approval for Two Rare Blood Disorder Therapies Qfitlia and Cablivi

R2 Retrotransposons Enable Efficient, DSB-Free Gene Insertion into Plant Genomes

Page 1 of 39